← Open Payments lookup

JAMES SULLIVAN: Open Payments

NPI 1588613020 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,950 in 131 payments from 29 companies in 2025. Trend: 2023 $2,465 · 2024 $2,801 · 2025 $8,950

Speaker / faculty: $5,250Food & beverage: $2,916Travel & lodging: $784
CompanyPaymentsAmount
Amgen Inc.18$3,618
Indivior Inc.10$3,192
Novo Nordisk Inc18$315
AstraZeneca Pharmaceuticals LP12$264
Otsuka America Pharmaceutical, Inc.8$177
Braeburn Inc.6$173
PFIZER INC.9$151
Lilly USA, LLC6$127
GlaxoSmithKline, LLC.4$101
Bayer Healthcare Pharmaceuticals Inc.5$101

Products named: REPATHA, SUBLOCADE, REXULTI, BRIXADI, AIRSUPRA, OTEZLA, Ozempic, Rybelsus.

Industry payments across AL — which companies pay providers there.